Vitestro raises $70 million in oversubscribed Series B financing to advance its robotic phlebotomy technology, with new investments from Labcorp Venture Fund and Mayo Clinic.
Amount Raised
$70 Million
Round Type
Series B
UtrechtBiotechnologySoftwareArtificial IntelligenceRoboticsInvestors
Description
Vitestro, a pioneer in medical robotics, has closed a $70 million Series B financing round. The funding will support the development of the Aletta Autonomous Robotic Phlebotomy Device and facilitate regulatory pathways. New strategic investors include Labcorp Venture Fund and Mayo Clinic. Proceeds will also aid in commercial readiness targeting both European and U.S
Who else raised in Robotics and Biotechnology around the same time
Companies in the same sectors as Vitestro that raised within 45 days of this round, from Fundz verified event records.
- Iridius raised $8.6M (Seed) on April 24, 2026.
- Bioxtreme raised $15M (Funding Round) on April 21, 2026.
- Smart Robotics raised $12M (Series A) on April 21, 2026.
- Antioch raised $8.5M (Seed) on April 20, 2026.
- Circle8 Group Inc raised $5.6M (Post-IPO Equity) on March 26, 2026.
- Autoscience raised $14M (Seed) on March 18, 2026.
Who to call at Vitestro, and when
A new round usually means Vitestro is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Vitestro raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Vitestro, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Vitestro. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Vitestro raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVitestro raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.